PolyPid (PYPD) stock

Worth $115MShares as of Dec 31

$6.31

+1.12%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score PYPD. It is too thinly traded for a fair Quality Score.

Healthcare · Medical Devices

NextNov 28, 2026 · In 18 days“aligned with D-PLEX₁₀₀ November 28, 2026 PDUFA goal date”FDA decision date · SEC filing · Oct 28

Follow PYPD's news. Pro members can get an alert when PolyPid files news, and see its trials, share raises, and its CEO's filings.

Get an alert when PYPD files newsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

What's next for PYPD, and how long its cash lasts

Next step the company has named

Nov 28In 18 days“aligned with D-PLEX₁₀₀ November 28, 2026 PDUFA goal date”FDA decision date · SEC filing · Oct 28

What it means: the date by which the FDA has said it aims to decide on the company’s application. The FDA can decide earlier, or extend the date.

For Pro members: 1 more milestone and 52 filings.

Cash runway Dec 31, 2025 balance sheet

$6.4M in cash

Fewer than four quarters of cash flow are on file.

What it means: a runway is counted only when each of the last four quarters used cash. The company's estimate is “into 2028” (8-K, Aug 12).

For Pro members: whether the cash lasts past the FDA date, the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (F-3, filed Jul 2, 2024)
At-the-market share sales program (424B5, filed Nov 8, 2024)

For Pro members: 1 raise and its amount, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

Get an alert when Dalit Hazan buys or sells

For Pro members: every trade, and Dalit Hazan’s 2 filings and quotes.

Get an alert before PYPD's FDA date

A free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

PYPD's latest filings

ISSUED BY POLYPID LTD. ON OCTOBER 28, 2026, TITLED "POLYPID UNVEILS EXPANDED PIPELINE STRATEGY, INTRODUCING PD01B, A NEW KYNATRIX-BASED PRODUCT CANDIDATE FOR THE TREATMENT OF DIABETIC FOOT…6-K, filed Oct 28
10 insider filingsForm 4, filed Jul 17
Annual report20-F, filed Feb 25

23 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why PYPD isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. PYPD trades about 138,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.